0 NASDAQ Companies - August 6, 2020Zscaler to Host Fourth Quarter and Fiscal Year 2020 Earnings Conference CallSAN JOSE, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, will release […]Read More
0 NASDAQ Companies - August 6, 2020InvisibleShield Introduces Screen Protection for the Samsung Galaxy Note20 5G and Note20 Ultra 5GSALT LAKE CITY, Aug. 06, 2020 (GLOBE NEWSWIRE) — InvisibleShield®, a ZAGG Brands (NASDAQ:ZAGG) company and the leading global innovator […]Read More
0 NASDAQ Companies - August 6, 2020Gear4 Introduces Protective Cases for Samsung Galaxy Note20 5G and Note20 Ultra 5GSALT LAKE CITY, Aug. 06, 2020 (GLOBE NEWSWIRE) — Gear4®, a ZAGG Brands (NASDAQ:ZAGG) company and the U.K.’s No. 1 […]Read More
0 NASDAQ Companies - August 6, 2020Exela Technologies Launches its Electronic Signature Platform: DrySignIRVING, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela”) (NASDAQ: XELA) today announced the launch of DrySign, […]Read More
0 NASDAQ Companies - August 6, 2020Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2021 and Provides Business UpdateU.S. COVID-19study showing positive safety profile for patients enrolled to dateBay Street NewsRead More
0 NASDAQ Companies - August 6, 2020Plug Power Announces 2020 Second Quarter ResultsLATHAM, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ:PLUG), a leading provider of hydrogen engines and fueling […]Read More
0 NASDAQ Companies - August 6, 2020Kelly® Reports Second Quarter EarningsFinancial HighlightsQ2 revenue declined 28.7% or 27.7% in constant currencyQ2 operating earnings of $11.1 million, down 68.2%, or down 50.4% […]Read More
0 NASDAQ Companies - August 6, 2020Selecta Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate UpdatesClosed strategic licensing agreement with Sobi for SEL-212 for $100 million in initial payments and up to $630 million in […]Read More
0 NASDAQ Companies - August 6, 2020Eloxx Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results and Provides Business UpdateEnrollment in our Phase 2 clinical trial program for ELX-02 in cystic fibrosis has been resumed in Europe and Israel […]Read More
0 NASDAQ Companies - August 6, 2020Intellia Therapeutics Announces Second Quarter 2020 Financial ResultsSubmitted first regulatory application to the U.K.’s MHRA to initiate a Phase 1 study of NTLA-2001 for the treatment of […]Read More